資料下載
Data download
熱門搜索：
Fitzgerald Industries International代理
Envirologix 轉(zhuǎn)基因快速檢測(cè)試紙
Epitomics現(xiàn)貨抗體目錄
ABgene代理30
EVE™ Slide（EVE細(xì)胞計(jì)數(shù)板）
Cayman Chemical 特約代理
法國(guó)ID-VET
美國(guó)Sutter 玻璃毛坯 BF100-50-10
Sinobio公司產(chǎn)品介紹
polysciences公司中國(guó)總代理
Abcam代理
genview
D12079BWestern Diet(高純度飼料)
TEAA Solution（貨號(hào)：553303;SP5890）
LSPN-50ABMI公司LYSOSTAPHIN中國(guó)總代理
天然小鼠補(bǔ)體C1q蛋白
發(fā)布時(shí)間：2026/3/6
點(diǎn)擊次數(shù)：84
美國(guó)Cayman Chem生物公司（Cayman Chemical Company）成立于1980年6月6日，由Kirk Maxey博士創(chuàng)立，總部位于密歇根州安娜堡，在捷克和愛(ài)沙尼亞設(shè)有分支機(jī)構(gòu)，是一家專注于提供生化研究工具及相關(guān)服務(wù)的企業(yè)。公司的創(chuàng)立源于Maxey博士的愿景——證明柳珊瑚作為前列腺素可再生、經(jīng)濟(jì)可行來(lái)源的價(jià)值，1981年8月，其團(tuán)隊(duì)從大開曼島附近采集的柳珊瑚樣本中成功提取出前列腺素A?，隨后推出五種前列腺素標(biāo)準(zhǔn)品，同年11月完成銷售，之后從丹佛遷至安娜堡并建立完整的合成化學(xué)實(shí)驗(yàn)室。
目前，公司員工超過(guò)400人，其中現(xiàn)場(chǎng)科研人員達(dá)150余人，產(chǎn)品銷往100多個(gè)國(guó)家和地區(qū)，擁有超過(guò)280,000平方英尺的研發(fā)與生產(chǎn)設(shè)施，并在復(fù)雜小分子合成、檢測(cè)技術(shù)及類花生酸類藥物活性成分生產(chǎn)工藝方面擁有多項(xiàng)。公司核心業(yè)務(wù)涵蓋研發(fā)、生產(chǎn)和銷售生命科學(xué)研究用生化試劑，同時(shí)提供合同研究服務(wù)，產(chǎn)品目錄超過(guò)28,000種，涵蓋小分子化合物、生化試劑、檢測(cè)試劑盒、抗體、重組蛋白等，廣泛應(yīng)用于癌癥、氧化損傷、表觀遺傳學(xué)、神經(jīng)科學(xué)、炎癥、代謝等多個(gè)研究領(lǐng)域。
公司注重產(chǎn)品質(zhì)量管控，生產(chǎn)與檢測(cè)流程通過(guò)多項(xiàng)國(guó)際認(rèn)證，包括ISO/IEC 17025:2017和ISO 17034:2016等，其捷克分支機(jī)構(gòu)還持有ISO 9001、ISO 14001及OHSAS 18001認(rèn)證。此外，公司還通過(guò)Cayman Biomedical Research Institute（CABRI）支持罕見(jiàn)病和孤兒藥的基礎(chǔ)研究，為相關(guān)科研人員提供資助，同時(shí)提供定制化化學(xué)合成、分析、檢測(cè)試劑盒開發(fā)、藥物發(fā)現(xiàn)等合同服務(wù)，服務(wù)對(duì)象包括學(xué)術(shù)研究機(jī)構(gòu)、生物技術(shù)公司及制藥企業(yè)。
關(guān)鍵詞：caymanchem，caymanchem上海代理，caymanchem中國(guó)代理，caymanchem北京代理，caymanchem江蘇代理， caymanchem廣東代理,10011671, 514010-96stripwells, 501700, 514531-96stripwells, 19082-50ug, 16156-50mg, 10008519-5mg, 17616, 501020-96stripwells、caymanchem、美國(guó)caymanchem生物公司、caymanchem、caymanchem試劑、caymanchem抗體、caymanchem檢測(cè)試劑盒、caymanchem重組蛋白、caymanchem生化試劑、caymanchem小分子化合物、caymanchem合同研究服務(wù)、caymanchem前列腺素、caymanchem癌癥研究試劑、caymanchem神經(jīng)科學(xué)試劑、caymanchem炎癥研究試劑、caymanchem代謝研究試劑、caymanchem ELISA試劑盒、caymanchem類花生酸、caymanchem藥物發(fā)現(xiàn)服務(wù)、caymanchem定制合成、caymanchem美國(guó)總部
特別告知：為保證產(chǎn)品質(zhì)量與良好性能，所以在購(gòu)買相應(yīng)產(chǎn)品的同時(shí)我司會(huì)收取一定量的運(yùn)輸費(fèi)用！！！本次報(bào)價(jià)有效時(shí)間為2026年3月6日---2026年12月20日。
（*此為部分產(chǎn)品價(jià)格,完整價(jià)格請(qǐng)下載文件)
貨號(hào) | 品名 | 規(guī)格 | 價(jià)格 | 品牌 |
10744 | JWH 200 4-hydroxyindole metabolite | 10mg | 6566 | Cayman |
10744 | JWH 200 4-hydroxyindole metabolite | 5mg | 4242 | Cayman |
10745 | JWH 200 5-hydroxyindole metabolite | 1mg | 1806 | Cayman |
10745 | JWH 200 5-hydroxyindole metabolite | 10mg | 6566 | Cayman |
10745 | JWH 200 5-hydroxyindole metabolite | 5mg | 4242 | Cayman |
10746 | JWH 200 6-hydroxyindole metabolite | 1mg | 1806 | Cayman |
10746 | JWH 200 6-hydroxyindole metabolite | 10mg | 6566 | Cayman |
10746 | JWH 200 6-hydroxyindole metabolite | 5mg | 4242 | Cayman |
10747 | JWH 200 7-hydroxyindole metabolite | 1mg | 1806 | Cayman |
10747 | JWH 200 7-hydroxyindole metabolite | 10mg | 6566 | Cayman |
10747 | JWH 200 7-hydroxyindole metabolite | 5mg | 4242 | Cayman |
10748 | Pifithrin-μ | 10mg | 1302 | Cayman |
10748 | Pifithrin-μ | 25mg | 2982 | Cayman |
10748 | Pifithrin-μ | 5mg | 840 | Cayman |
10748 | Pifithrin-μ | 50mg | 5502 | Cayman |
10749 | Methylhexanamine (hydrochloride) | 10mg | 1050 | Cayman |
10749 | Methylhexanamine (hydrochloride) | 5mg | 574 | Cayman |
10749 | Methylhexanamine (hydrochloride) | 50mg | 4368 | Cayman |
10755 | G9a-like protein (human recombinant) | 50ug | 6104 | Cayman |
10765 | RIZ1 (human recombinant) | 250ug | 5530 | Cayman |
10770 | DNA Methyltransferase 3L (human recombinant) | 25ug | 8428 | Cayman |
10774 | UTX (human, recombinant) | 25ug | 5922 | Cayman |
10782 | Gcn5 (human, recombinant) | 100ug | 6664 | Cayman |
10783 | TIP60 (human, recombinant) | 100ug | 7602 | Cayman |
10784 | PAD1 (human, recombinant) | 100ug | 7392 | Cayman |
10785 | PAD2 (human, recombinant) | 50ug | 7686 | Cayman |
10786 | PAD3 (human, recombinant) | 100ug | 7392 | Cayman |
10787 | CCG-100602 | 10mg | 1106 | Cayman |
10787 | CCG-100602 | 25mg | 2562 | Cayman |
10787 | CCG-100602 | 5mg | 588 | Cayman |
10787 | CCG-100602 | 50mg | 4508 | Cayman |
10790 | Xanomeline (oxalate) | 1mg | 518 | Cayman |
10790 | Xanomeline (oxalate) | 10mg | 2464 | Cayman |
10790 | Xanomeline (oxalate) | 5mg | 1848 | Cayman |
10791 | CAY10647 | 1mg | 1680 | Cayman |
10791 | CAY10647 | 10mg | 13188 | Cayman |
10791 | CAY10647 | 5mg | 7420 | Cayman |
10792 | SC-26196 | 1mg | 504 | Cayman |
10792 | SC-26196 | 10mg | 2604 | Cayman |
10792 | SC-26196 | 25mg | 5880 | Cayman |
10792 | SC-26196 | 5mg | 1890 | Cayman |
10793 | AG-879 | 10mg | 1680 | Cayman |
10793 | AG-879 | 25mg | 3934 | Cayman |
10793 | AG-879 | 5mg | 1050 | Cayman |
10793 | AG-879 | 50mg | 7336 | Cayman |
10794 | 22-Oxacalcitriol | 1mg | 1890 | Cayman |
10794 | 22-Oxacalcitriol | 10mg | 10472 | Cayman |
10794 | 22-Oxacalcitriol | 5mg | 6818 | Cayman |
10794 | 22-Oxacalcitriol | 500ug | 1050 | Cayman |
10795 | (±)-JWH 073 N-(3-hydroxybutyl) metabolite | 1mg | 1806 | Cayman |
10795 | (±)-JWH 073 N-(3-hydroxybutyl) metabolite | 10mg | 6566 | Cayman |
10795 | (±)-JWH 073 N-(3-hydroxybutyl) metabolite | 5mg | 4242 | Cayman |
10796 | (±)-JWH 018 N-(4-hydroxypentyl) metabolite | 1mg | 1806 | Cayman |
10796 | (±)-JWH 018 N-(4-hydroxypentyl) metabolite | 10mg | 6566 | Cayman |
10796 | (±)-JWH 018 N-(4-hydroxypentyl) metabolite | 5mg | 4242 | Cayman |
10797 | JWH 307 | 1mg | 686 | Cayman |
10797 | JWH 307 | 10mg | 3304 | Cayman |
10797 | JWH 307 | 25mg | 8218 | Cayman |
10797 | JWH 307 | 5mg | 2660 | Cayman |
10798 | RCS-4-C4 homolog | 1mg | 966 | Cayman |
10798 | RCS-4-C4 homolog | 10mg | 7350 | Cayman |
10798 | RCS-4-C4 homolog | 5mg | 4158 | Cayman |
10802 | CCG-50014 | 1mg | 420 | Cayman |
10802 | CCG-50014 | 10mg | 2254 | Cayman |
10802 | CCG-50014 | 25mg | 5124 | Cayman |
10802 | CCG-50014 | 5mg | 1442 | Cayman |
10803 | Autotaxin (human, recombinant) | 100ug | 7602 | Cayman |
10804 | CAY10649 | 1mg | 728 | Cayman |
10804 | CAY10649 | 10mg | 5544 | Cayman |
10804 | CAY10649 | 5mg | 3178 | Cayman |
10805 | ANGPTL3 (human) Monoclonal Antibody (Clone Kairos-37) | 100ug | 4970 | Cayman |
10805 | ANGPTL3 (human) Monoclonal Antibody (Clone Kairos-37) | 50ug | 4060 | Cayman |
10806 | ANGPTL3 (mouse) Monoclonal Antibody (Clone Kairos3-1541) | 100ug | 4970 | Cayman |
10806 | ANGPTL3 (mouse) Monoclonal Antibody (Clone Kairos3-1541) | 50ug | 4060 | Cayman |
10807 | ANGPTL3 (mouse) Monoclonal Antibody (Clone Kairos3-3741) | 100ug | 4970 | Cayman |
10807 | ANGPTL3 (mouse) Monoclonal Antibody (Clone Kairos3-3741) | 50ug | 4060 | Cayman |
10809 | Interleukin-33 (human) Monoclonal Antibody (Clone IL33305B) | 100ug | 4606 | Cayman |
10809 | Interleukin-33 (human) Monoclonal Antibody (Clone IL33305B) | 50ug | 3304 | Cayman |
10810 | Interleukin-33 Monoclonal Antibody (Clone IL333068A) | 100ug | 4970 | Cayman |
10810 | Interleukin-33 Monoclonal Antibody (Clone IL333068A) | 50ug | 4060 | Cayman |
10811 | Interleukin-33 Monoclonal Antibody (Clone IL33026B) | 100ug | 4970 | Cayman |
10811 | Interleukin-33 Monoclonal Antibody (Clone IL33026B) | 50ug | 4060 | Cayman |
10812 | Vaspin (human) Monoclonal Antibody (Clone VP63) | 100ug | 5796 | Cayman |
10812 | Vaspin (human) Monoclonal Antibody (Clone VP63) | 50ug | 4060 | Cayman |
10813 | Nampt Monoclonal Antibody (Clone OMNI 379) | 100ug | 5222 | Cayman |
10813 | Nampt Monoclonal Antibody (Clone OMNI 379) | 50ug | 3500 | Cayman |
10814 | FTO (mouse) Monoclonal Antibody (Clone FT 62-6) | 100ug | 4970 | Cayman |
10814 | FTO (mouse) Monoclonal Antibody (Clone FT 62-6) | 50ug | 4060 | Cayman |
10815 | FTO (mouse) Monoclonal Antibody (Clone FT 342-1) | 100ug | 4970 | Cayman |
10815 | FTO (mouse) Monoclonal Antibody (Clone FT 342-1) | 50ug | 4060 | Cayman |
10816 | FTO (human) Monoclonal Antibody (Clone FT 86-4) | 100ug | 4970 | Cayman |
10816 | FTO (human) Monoclonal Antibody (Clone FT 86-4) | 50ug | 4060 | Cayman |
10818 | Coumarin Boronic Acid pinacolate ester | 10mg | 2072 | Cayman |
10818 | Coumarin Boronic Acid pinacolate ester | 100mg | 14602 | Cayman |
10818 | Coumarin Boronic Acid pinacolate ester | 5mg | 1218 | Cayman |
10818 | Coumarin Boronic Acid pinacolate ester | 50mg | 8526 | Cayman |
10823 | SMAD2 Polyclonal Antibody | 100ug | 4802 | Cayman |
10824 | JWH 031 | 10mg | 2030 | Cayman |
10824 | JWH 031 | 25mg | 4746 | Cayman |
10824 | JWH 031 | 5mg | 1078 | Cayman |
10825 | JWH 145 | 1mg | 686 | Cayman |
10825 | JWH 145 | 10mg | 4704 | Cayman |
10825 | JWH 145 | 25mg | 9268 | Cayman |
10825 | JWH 145 | 5mg | 2660 | Cayman |
10826 | JWH 147 | 10mg | 2030 | Cayman |
10826 | JWH 147 | 25mg | 4746 | Cayman |
10826 | JWH 147 | 5mg | 1078 | Cayman |
10827 | JWH 370 | 1mg | 686 | Cayman |
10827 | JWH 370 | 10mg | 4704 | Cayman |
10827 | JWH 370 | 5mg | 2660 | Cayman |
10828 | JWH 369 | 1mg | 686 | Cayman |
10828 | JWH 369 | 10mg | 4704 | Cayman |
10828 | JWH 369 | 5mg | 2660 | Cayman |
10829 | JWH 368 | 1mg | 686 | Cayman |
10829 | JWH 368 | 10mg | 4704 | Cayman |
10829 | JWH 368 | 25mg | 9268 | Cayman |
10829 | JWH 368 | 5mg | 2660 | Cayman |
10830 | JWH 309 | 1mg | 686 | Cayman |
10830 | JWH 309 | 10mg | 4704 | Cayman |
10830 | JWH 309 | 5mg | 2660 | Cayman |
10831 | JWH 030 | 1mg | 686 | Cayman |
10831 | JWH 030 | 10mg | 4704 | Cayman |
10831 | JWH 030 | 5mg | 2660 | Cayman |
10832 | SMAD3 Polyclonal Antibody | 100ug | 4802 | Cayman |
10833 | ABL 127 | 1mg | 574 | Cayman |
10833 | ABL 127 | 10mg | 3836 | Cayman |
10833 | ABL 127 | 5mg | 2072 | Cayman |
10838 | SMAD4 Polyclonal Antibody | 100ug | 4802 | Cayman |
10839 | SMAD6 Polyclonal Antibody | 100ug | 4760 | Cayman |
10842 | (±)-Norepinephrine-d6 (hydrochloride) | 1mg | 1988 | Cayman |
10842 | (±)-Norepinephrine-d6 (hydrochloride) | 10mg | 14910 | Cayman |
10842 | (±)-Norepinephrine-d6 (hydrochloride) | 5mg | 8960 | Cayman |
10845 | SMAD7 Polyclonal Antibody | 100ug | 4802 | Cayman |
10848 | JWH 073 2-methylnaphthyl analog | 1mg | 1260 | Cayman |
10848 | JWH 073 2-methylnaphthyl analog | 10mg | 9744 | Cayman |
10848 | JWH 073 2-methylnaphthyl analog | 5mg | 5488 | Cayman |
10849 | JWH 016 | 10mg | 2030 | Cayman |
10849 | JWH 016 | 25mg | 4746 | Cayman |
10849 | JWH 016 | 5mg | 1078 | Cayman |
10850 | JWH 020 | 10mg | 2030 | Cayman |
10850 | JWH 020 | 25mg | 4746 | Cayman |
10850 | JWH 020 | 5mg | 1078 | Cayman |
10851 | Guanabenz (hydrochloride) | 100mg | 2464 | Cayman |
10851 | Guanabenz (hydrochloride) | 25mg | 700 | Cayman |
10851 | Guanabenz (hydrochloride) | 50mg | 1316 | Cayman |
10854 | Histone H4 Peptide Substrate (1-21) | 1mg | 2884 | Cayman |
10857 | CAY10654 | 1mg | 462 | Cayman |
10857 | CAY10654 | 10mg | 3472 | Cayman |
10857 | CAY10654 | 25mg | 7574 | Cayman |
10857 | CAY10654 | 5mg | 1988 | Cayman |
10858 | Cinnamyl-3,4-dihydroxy-α-Cyanocinnamate | 10mg | 1036 | Cayman |
10858 | Cinnamyl-3,4-dihydroxy-α-Cyanocinnamate | 100mg | 6958 | Cayman |
10858 | Cinnamyl-3,4-dihydroxy-α-Cyanocinnamate | 5mg | 546 | Cayman |
10858 | Cinnamyl-3,4-dihydroxy-α-Cyanocinnamate | 50mg | 4284 | Cayman |
10862 | AM2201 2'-naphthyl isomer | 1mg | 1260 | Cayman |
當(dāng)前位置：
